Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 7/20 | 0.44 |
| ▸ | MEN1 | O00255 | 6/20 | 0.43 |
| ▸ | POLB | P06746 | 3/20 | 0.43 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.41 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.41 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | KIFC1 | Q9BW19 | 2/20 | 0.40 |
| ▸ | GAA | P10253 | 2/20 | 0.40 |
| ▸ | PKM | P14618 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | NCS1 | P62166 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL784578 | 0.85 | LMNA (0.53) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL784099 | 0.83 | NPSR1 (0.49) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL783546 | 0.82 | LMNA (0.48) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL6606104 | 0.80 | MAPK1 (0.47) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL784102 | 0.78 | GLA (0.43) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL14921059 | 0.76 | GAA (0.44) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL783552 | 0.76 | LMNA (0.51) | KMT2AMEN1POLBGLAGAA | |
| SCHEMBL18335147 | 0.74 | GLA (0.46) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL15061809 | 0.73 | GLA (0.47) | KMT2AMEN1POLBCYP1A2CYP3A4 | |
| SCHEMBL4418292 | 0.72 | GLA (0.45) | KMT2AMEN1POLBCYP1A2CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7754741-B2 | Pyridine derivatives as fungicidal compounds | BAYER CROPSCIENCE S.A. (FR) | 2010-07-13 | — | — | US | disclosed |
| US-20060052366-A1 | Pyridine derivatives as fungicidal compounds | BAYER SAS (FR) | 2006-03-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060052366-A1 | Pyridine derivatives as fungicidal compounds | CYP3A7, CYP4B1, CYP4X1 | KMT2A 3663/4885MEN1 2071/4885POLB 4012/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.